Completed PHASE3 INTERVENTIONAL 2-arm NCT03063073

Efficacy and Safety of Dexmedetomidine Added to Modified Pectoral's Block (pec's)

Efficacy and Safety of Dexmedetomidine Added to Modified Pectoral's Block in Patient Undergoing Breast Cancer Surgery :A Comparative Study

Sponsor: South Egypt Cancer Institute

Conditions Breast Cancer Female

Interventions Bupivacaine Injection [Marcaine] Dexmedetomidine Injection [Precedex]

Updated 9 times since 2017 Last updated: Feb 9, 2026 Started: Feb 25, 2017 Primary completion: May 30, 2017 Completion: Jun 15, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Breast Cancer Female, this trial is completed. The trial is conducted by South Egypt Cancer Institute and has accumulated 9 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

9 versions recorded

Feb 2026 — Present [monthly]

Completed PHASE3

Status: Unknown → Completed
Sep 2025 — Feb 2026 [monthly]

Unknown PHASE3
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3

▶ Show 4 earlier versions

Sep 2020 — Jan 2021 [monthly]

Unknown Status PHASE3
Mar 2019 — Sep 2020 [monthly]

Unknown Status PHASE3

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Mar 2019 [monthly]

Not Yet Recruiting PHASE3
Mar 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE3

First recorded

Feb 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

South Egypt Cancer Institute

Data source: South Egypt Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Asyut, Egypt